OREANDA-NEWS. March 17, 2015. Ergomed plc (LSE: ERGO or 'Ergomed') is pleased that its group company PrimeVigilance, one of the world's leading pharmacovigilance and medical information services providers, has been invited to speak at the DIA USA 2015 51st Annual Meeting taking place from 14th to 18th June, 2015. The event will be held at the Walter E. Washington Convention Center in Washington, DC.

Now in its 51st year, the DIA USA Annual Meeting is one of the largest multidisciplinary events that brings together Life Sciences professionals across all disciplines, with a common goal to foster innovation that will lead to the development of safe and effective medical products and therapies for patients.

Dr Joerg Seebeck will join the Clinical Safety and Pharmacovigilance Symposium panel on Wednesday 17th June at 10:30 am on the "Risk of Drug-Induced QT Interval Prolongation by Monoclonal Antibody Medicines: A Review of Data from an EU Database."

Mr Andrew Harbrow will join the Validation Symposium panel on Wednesday 17th June at 1:30 pm on the establishment of a new Medical Information Database: "To Validate or Not to Validate - That Is the Question."

Miroslav Reljanovic M.D., CEO of Ergomed said: "PrimeVigilance is a fast growing Ergomed group company that is a committed to patient safety services and is at the forefront of developments in the Pharmacovigilance and Medical Information industry providing quality services and consultancy to our international clients. We are pleased that PrimeVigilance has been invited to speak at one of the largest and most prestigious events in the sector."